|
|
Line 334: |
Line 334: |
| *Citation: Campagna, Davide; Cibella, Fabio; Caponnetto, Pasquale; Amaradio, Maria Domenica; Caruso, Massimo; Morjaria, Jaymin B.; Malerba, Mario; Polosa, Riccardo (2016). Changes in breathomics from a 1-year randomized smoking cessation trial of electronic cigarettes. European Journal of Clinical Investigation, (), –. doi:10.1111/eci.12651 | | *Citation: Campagna, Davide; Cibella, Fabio; Caponnetto, Pasquale; Amaradio, Maria Domenica; Caruso, Massimo; Morjaria, Jaymin B.; Malerba, Mario; Polosa, Riccardo (2016). Changes in breathomics from a 1-year randomized smoking cessation trial of electronic cigarettes. European Journal of Clinical Investigation, (), –. doi:10.1111/eci.12651 |
|
| |
|
| ===2016: Respiratory infections and pneumonia: potential benefits of switching from smoking to Vaping=== | | ===2016: [https://pneumonia.biomedcentral.com/articles/10.1186/s41479-016-0001-2 Respiratory infections and pneumonia: potential benefits of switching from smoking to Vaping]=== |
| (PDF 4 pages)
| | *Also, given that the propylene glycol in EC aerosols is a potent bactericidal agent, switching from smoking to regular vaping is likely to produce additional lung health benefits. |
| -Also, given that the propylene glycol in EC aerosols is a potent bactericidal agent, switching from smoking to regular vaping is likely to produce additional lung health benefits.
| | *In conclusion, smokers who quit by switching to regular ECs use can reduce risk and reverse harm from tobacco smoking. |
| -In conclusion, smokers who quit by switching to regular ECs use can reduce risk and reverse harm from tobacco smoking.
| | *Innovation in the e-vapour category is likely not only to further minimise residual health risks, but also to maximise health benefits. |
| -Innovation in the e-vapour category is likely not only to further minimise residual health risks, but also to maximise health benefits.
| | *[https://pneumonia.biomedcentral.com/counter/pdf/10.1186/s41479-016-0001-2.pdf PDF] |
| | *Citation: Campagna, D., Amaradio, M.D., Sands, M.F. et al. Respiratory infections and pneumonia: potential benefits of switching from smoking to vaping. pneumonia 8, 4 (2016). https://doi.org/10.1186/s41479-016-0001-2 |
|
| |
|
| ===2016: Persisting long term benefits of smoking abstinence and reduction in asthmatic smokers who have switched to electronic cigarettes=== | | ===2016: Persisting long term benefits of smoking abstinence and reduction in asthmatic smokers who have switched to electronic cigarettes=== |